Dactinomycin
Who holds supplier records for Dactinomycin? 2 organisations hold a current record for Dactinomycin: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (1) and China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dactinomycin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dactinomycin
Reading the evidence
- 2 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 2 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (2)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dactinomycin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CONCORD BIOTECH LTDIndia Company GMP cert on recordActive DMF 34247 · latest filing Nov 2019
- Zhejiang Hisun Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 20658 · latest filing Jun 2007
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (2)
Organisations whose Type II DMFs for Dactinomycin are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- SIGMA CHEMICAL COInactive DMF 13633 · filed Sept 1998
- SIGMA ALDRICH ISRAEL LTDInactive DMF 3538 · filed Apr 1979
Overview
Dactinomycin is a chromopeptide antibiotic used in chemotherapy that inhibits RNA synthesis. It is mainly employed in the treatment of various types of cancer like Wilms’ tumor and rhabdomyosarcoma.
Chemical identity
- IUPAC name
- 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
- Canonical SMILES
- C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C
- InChIKey
- RJURFGZVJUQBHK-IIXSONLDSA-N
- Synonyms
- Actinomycin D, actinomycin c1, actinomycin i1, actinomycin iv, actinomycin x1, actinomycin-d, cosmegen, dactinomycinum, dilactone actinomycin d acid, gnf-pf-2290, meractinomycin, nci-c04682
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Actinomycin
- Mechanism of action
- Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dactinomycin?
2 organisations hold an active US FDA Type II Drug Master File or a CEP for Dactinomycin: CONCORD BIOTECH LTD (India) and Zhejiang Hisun Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dactinomycin Drug Master Files are active?
CONCORD BIOTECH LTD (DMF 34247) and Zhejiang Hisun Pharmaceutical Co., Ltd. (DMF 20658). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dactinomycin records mean?
2 organisations have only inactive Type II DMFs for Dactinomycin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Dactinomycin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dactinomycin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.